| Code | Description | Claims | Beneficiaries | Total Paid |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,126 |
1,012 |
$2.13M |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
302 |
295 |
$1.20M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,381 |
3,162 |
$559K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
610 |
552 |
$98K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
419 |
359 |
$54K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
216 |
189 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
203 |
192 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
3,083 |
2,633 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,669 |
1,422 |
$8K |
| 80053 |
Comprehensive metabolic panel |
964 |
828 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
161 |
153 |
$7K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
144 |
128 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
165 |
155 |
$6K |
| 87503 |
|
203 |
192 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
87 |
75 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
37 |
29 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
43 |
37 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17 |
12 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
97 |
88 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
72 |
70 |
$991.20 |
| 80061 |
Lipid panel |
96 |
88 |
$910.52 |
| 82172 |
|
60 |
55 |
$727.57 |
| 83695 |
|
60 |
55 |
$627.43 |
| 85027 |
|
132 |
124 |
$604.92 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
279 |
242 |
$534.46 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
117 |
107 |
$390.08 |
| 81003 |
|
198 |
168 |
$292.48 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
12 |
$280.05 |
| 84484 |
|
24 |
14 |
$188.82 |
| 86803 |
|
12 |
12 |
$156.97 |
| 82607 |
|
18 |
14 |
$156.45 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
98 |
85 |
$123.27 |
| 81001 |
|
62 |
54 |
$109.68 |
| 81025 |
|
13 |
13 |
$62.85 |
| 83690 |
|
20 |
13 |
$46.57 |
| 80076 |
|
14 |
13 |
$12.45 |